Skip to main content

Advertisement

Log in

A Systematic Review of Adherence to Cardiovascular Medications in Resource-Limited Settings

  • Reviews
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Background

Medications are a cornerstone of the prevention and management of cardiovascular disease. Long-term medication adherence has been the subject of increasing attention in the developed world but has received little attention in resource-limited settings, where the burden of disease is particularly high and growing rapidly. To evaluate prevalence and predictors of non-adherence to cardiovascular medications in this context, we systematically reviewed the peer-reviewed literature.

Methods

We performed an electronic search of Ovid Medline, Embase and International Pharmaceutical Abstracts from 1966 to August 2010 for studies that measured adherence to cardiovascular medications in the developing world. A DerSimonian-Laird random effects method was used to pool the adherence estimates across studies. Between-study heterogeneity was estimated with an I2 statistic and studies were stratified by disease group and the method by which adherence was assessed. Predictors of non-adherence were also examined.

Findings

Our search identified 2,353 abstracts, of which 76 studies met our inclusion criteria. Overall adherence was 57.5% (95% confidence interval [CI] 52.3% to 62.7%; I2 0.98) and was consistent across study subgroups. Studies that assessed adherence with pill counts reported higher levels of adherence (62.1%, 95% CI 49.7% to 73.8%; I2 0.83) than those using self-report (54.6%, 95% CI 47.7% to 61.5%; I2 0.93). Adherence did not vary by geographic region, urban vs. rural settings, or the complexity of a patient’s medication regimen. The most common predictors of poor adherence included poor knowledge, negative perceptions about medication, side effects and high medication costs.

Interpretation

Our study indicates that adherence to cardiovascular medication in resource-limited countries is sub-optimal and appears very similar to that observed in resource-rich countries. Efforts to improve adherence in resource-limited settings should be a priority given the burden of heart disease in this context, the central role of medications in their management, and the clinical and economic consequences of non-adherence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. WHO. Adherence to Long-term Therapies: Evidence for action. World Health Organisation 2003.

  2. Choudhry NK. Improving the pathway from cardiovascular medication prescribing to longer-term adherence: new results about old issues. Circ Cardiovasc Qual Outcomes. 2010;3:223–5.

    Article  PubMed  Google Scholar 

  3. Choudhry NK, Setoguchi S, Levin R, Winkelmayer WC, Shrank WH. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf. 2008;17:1189–96.

    Article  PubMed  Google Scholar 

  4. Choudhry NK, Winkelmayer WC. Medication adherence after myocardial infarction: a long way left to go. J Gen Intern Med. 2008;23:216–8.

    Article  PubMed  Google Scholar 

  5. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357–66.

    Article  PubMed  CAS  Google Scholar 

  6. Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296:679–90.

    Article  PubMed  CAS  Google Scholar 

  7. International Monetary Fund. World economic and financial surveys: List of emerging and developing economies; 2009.

  8. Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses.

  9. West S, King V, Carey ST, et al. Systems to Rate the Strength Of Scientific Evidence: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services; 2002 April 2002.

  10. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.

    Article  PubMed  CAS  Google Scholar 

  11. Jaynes ET. Confidence intervals vs. Bayesian intervals. In: Harper WL, Hooker CA, eds. Foundations of probability theory, statistical inference, and statistical theories of science. Dordrecht: Reidel; 1976.

    Google Scholar 

  12. Stuart A, Ord JK. Kendall's Advanced Theory of Statistics. 6th ed. London: Arnold Publishers; 1994.

    Google Scholar 

  13. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  PubMed  CAS  Google Scholar 

  14. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res. 1993;2:121–45.

    Article  PubMed  CAS  Google Scholar 

  15. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.

    Article  PubMed  Google Scholar 

  16. Akpa MR, Agomuoh DI, Odia OJ. Drug compliance among hypertensive patients in Port Harcourt, Nigeria. Niger J Med. 2005;14:55–7.

    PubMed  CAS  Google Scholar 

  17. Almas A, Hameed A, Ahmed B, Islam M. Compliance to antihypertensive therapy. J Coll Physicians Surg Pak. 2006;16:23–6.

    PubMed  Google Scholar 

  18. Amira OC, Okubadejo NU. Frequency of complementary and alternative medicine utilization in hypertensive patients attending an urban tertiary care centre in Nigeria. BMC Complement Altern Med. 2007;7:30.

    Article  PubMed  Google Scholar 

  19. Ben Abdelaziz A, Ben Othman A, Mandhouj O, Gaha R, Bouabid Z, Ghannem H. [Audit of management of arterial hypertension in primary health care in Sousse]. Tunis Med. 2006;84:148–54.

    PubMed  Google Scholar 

  20. Bharucha NE, Kuruvilla T. Hypertension in the Parsi community of Bombay: a study on prevalence, awareness and compliance to treatment. BMC Public Health. 2003;3:1.

    Article  PubMed  Google Scholar 

  21. Bovet P, Burnier M, Madeleine G, Waeber B, Paccaud F. Monitoring one-year compliance to antihypertension medication in the Seychelles. Bull World Health Organ. 2002;80:33–9.

    PubMed  Google Scholar 

  22. Buabeng K. Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana. J Pharm Pharm Sci. 2004;7:350–2.

    Google Scholar 

  23. Buchanan N, Shuenyane E, Mashigo S, Mtangai P, Unterhalter B. Factors influencing drug compliance in ambulatory Black urban patients. S Afr Med J. 1979;55:368–73.

    PubMed  CAS  Google Scholar 

  24. Castro RA, Moncau JE, Marcopito LF. Hypertension prevalence in the city of Formiga, MG, Brazil. Arq Bras Cardiol. 2007;88:334–9.

    Article  PubMed  Google Scholar 

  25. Chen W, Huang X, Zheng J, Huang W. Survey on drug compliance of patients with hypertension in residents at Shangmeilin new community in Shenzhen. Chin J Clin Rehabil. 2004;8:5790–1.

    Google Scholar 

  26. Coelho EB. Moyses Neto M, Palhares R, Cardoso MC, Geleilete TJ, Nobre F. Relationship between regular attendance to ambulatory appointments and blood pressure control among hypertensive patients. Arq Bras Cardiol. 2005;85:157–61.

    PubMed  Google Scholar 

  27. de Souza WA, Yugar-Toledo JC, Bergsten-Mendes G, Sabha M, Moreno H Jr. Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension. Am J Health Syst Pharm. 2007;64:1955–61.

    Article  PubMed  Google Scholar 

  28. Dennison CR, Peer N, Steyn K, Levitt NS, Hill MN. Determinants of hypertension care and control among peri-urban Black South Africans: the HiHi study. Ethn Dis. 2007;17:484–91.

    PubMed  Google Scholar 

  29. Elzubier AG, Husain AA, Suleiman IA, Hamid ZA. Drug compliance among hypertensive patients in Kassala, eastern Sudan. East Mediterr Health J. 2000;6:100–5.

    PubMed  CAS  Google Scholar 

  30. Feng L, Lui J, Duan Y. Medical order-obeying behavior in 164 patients with essential hypertension. Chin J Clin Rehabil. 2005;9:150–1.

    Google Scholar 

  31. Fodor GJ, Kotrec M, Bacskai K, et al. Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-European study. J Hypertens. 2005;23:1261–6.

    Article  PubMed  CAS  Google Scholar 

  32. Hadi N, Rostami-Gooran N. Determinant factors of medication compliances in hypertensive patients of Shiraz, Iran. Archives of Iranian Medicine. 2004;7:292–6.

    Google Scholar 

  33. Hassan NB, Hasanah CI, Foong K, et al. Identification of psychosocial factors of noncompliance in hypertensive patients. J Hum Hypertens. 2006;20:23–9.

    Article  PubMed  CAS  Google Scholar 

  34. Hungerbuhler P, Bovet P, Shamlaye C, Burnand B, Waeber B. Compliance with medication among outpatients with uncontrolled hypertension in the Seychelles. Bull World Health Organ. 1995;73:437–42.

    PubMed  CAS  Google Scholar 

  35. Joshi PP, Salkar RG, Heller RF. Determinants of poor blood pressure control in urban hypertensives of central India. J Hum Hypertens. 1996;10:299–303.

    PubMed  CAS  Google Scholar 

  36. Konin C, Adoh M, Coulibaly I, et al. Black Africans' compliance to antihypertensive treatment. Arch Mal Coeur Vaiss. 2007;100:630–4.

    PubMed  CAS  Google Scholar 

  37. Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill MN. Cross-cultural validation of the hill-bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting. Ethn Dis. 2006;16:286–91.

    PubMed  Google Scholar 

  38. Li W, Jiang X, Ma H, et al. Awareness, treatment and control of hypertension in patients attending hospital clinics in China. J Hypertens. 2003;21:1191–7.

    Article  PubMed  Google Scholar 

  39. Lim TO, Ngah BA. The Mentakab Hypertension Study project. Part II–Why do hypertensives drop out of treatment? Singapore Med J. 1991;32:249–51.

    PubMed  CAS  Google Scholar 

  40. Lu J, Li LM, Cao WH, Zhan SY, Hu YH. Postmarketing surveillance on Benazepril. Zhonghua Liu Xing Bing Xue Za Zhi. 2004;25:412–6.

    PubMed  Google Scholar 

  41. Lunt DW, Edwards PR, Steyn K, Lombard CJ, Fehrsen GS. Hypertension care at a Cape Town community health centre. S Afr Med J. 1998;88:544–8.

    PubMed  CAS  Google Scholar 

  42. Maro EE, Lwakatare J. Medication compliance among Tanzanian hypertensives. East Afr Med J. 1997;74:539–42.

    PubMed  CAS  Google Scholar 

  43. Marshall RA, Yach D. Management of hypertension in Mamre women. S Afr Med J. 1988;74:346–8.

    PubMed  CAS  Google Scholar 

  44. Naddaf A. Lifestyle of hypertensive patients and their drug compliance. Bulletin of Pharmaceutical Sciences. 2004;27:307–14.

    Google Scholar 

  45. Nugmanova A, Pillai G, Nugmanova D, Kuter D. Improving the management of hypertension in Kazakhstan: Implications for improving clinical practice, patient behaviors, and health outcomes. Global Public Health. 2008;3:214–31.

    Article  PubMed  CAS  Google Scholar 

  46. Peltzer K. Health beliefs and prescription medication compliance among diagnosed hypertension clinic attenders in a rural South African Hospital. Curationis. 2004;27:15–23.

    PubMed  CAS  Google Scholar 

  47. Qureshi NN, Hatcher J, Chaturvedi N, Jafar TH. Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trial. BMJ. 2007;335:1030.

    Article  PubMed  Google Scholar 

  48. Roy PK, Arif SM, Alam MR, Khan FD, Ahmad Q, Chowdhury SG. Stroke in patients having inadequate or irregular antihypertensive therapy. Bangladesh Med Res Counc Bull. 1990;16:52–7.

    PubMed  CAS  Google Scholar 

  49. Salako BL, Ajose FA, Lawani E. Blood pressure control in a population where antihypertensives are given free. East Afr Med J. 2003;80:529–31.

    PubMed  CAS  Google Scholar 

  50. Salome Kruger H, Gerber JJ. Health beliefs and compliance of black South African outpaitents with antihypertensive medication. Journal of Social and Administrative Pharmacy. 1998;15:201–9.

    Google Scholar 

  51. Saunders LD, Irwig LM, Gear JS, Ramushu DL. A randomized controlled trial of compliance improving strategies in Soweto hypertensives. Med Care. 1991;29:669–78.

    Article  PubMed  CAS  Google Scholar 

  52. Sookaneknun P, Richards RM, Sanguansermsri J, Teerasut C. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes. Ann Pharmacother. 2004;38:2023–8.

    Article  PubMed  Google Scholar 

  53. Stein CM, Neill P, Mwaluko GM, Kusema T. Combination of a thiazide, a vasodilator and reserpine compared with methyldopa plus hydrochlorothiazide in the treatment of hypertension in Zimbabwe. S Afr Med J. 1990;77:243–5.

    PubMed  CAS  Google Scholar 

  54. Supramaniam V. Study of Malaysian military hypertensives–therapy compliance. Med J Malaysia. 1982;37:249–52.

    PubMed  CAS  Google Scholar 

  55. Unterhalter B. Compliance with Western medical treatment in a group of black ambulatory hospital patients. Soc Sci Med [Med Psychol Med Sociol]. 1979;13A:621–30.

    CAS  Google Scholar 

  56. Xiao H-M, Jiang X-Y. Drug compliance of elderly patients with hypertension. Chin J Clin Rehabil. 2005;9:30–1.

    Google Scholar 

  57. Youssef RM, Moubarak II. Patterns and determinants of treatment compliance among hypertensive patients. East Mediterr Health J. 2002;8:579–92.

    PubMed  CAS  Google Scholar 

  58. Yusuff K, Alabi A. Assessing patient adherence to anti-hypertensive drug therapy: Can a structured pharmacist-conducted interview separated the wheat from the chaff? International Journal of Pharmacy Practice. 2007;15:295–300.

    Article  Google Scholar 

  59. Yusuff KB, Balogun OB. Pattern of drug utilization among hypertensives in a Nigerian teaching hospital. Pharmacoepidemiol Drug Saf. 2005;14:69–74.

    Article  PubMed  CAS  Google Scholar 

  60. Zdrojewski T, Januszko W, Drygas W, et al. Pharmacotherapy of arterial hypertension and pharmacoeconomic aspects of hypotensive therapy in elderly patients in Poland. Pol Arch Med Wewn. 1999;102:787–95.

    PubMed  CAS  Google Scholar 

  61. Jiang X, Li W, Ma L, Kong L, Jin S, Liu L. Knowledge on hypertension and the effect of management on hypertension in patients attending hospital clinics. Zhonghua Liu Xing Bing Xue Za Zhi. 2002;23:269–72.

    PubMed  Google Scholar 

  62. Khalil SA, Elzubier AG. Drug compliance among hypertensive patients in Tabuk, Saudi Arabia. J Hypertens. 1997;15:561–5.

    Article  PubMed  CAS  Google Scholar 

  63. Toprak D, Demir S. Treatment choices of hypertensive patients in Turkey. Behav Med. 2007;33:5–10.

    Article  PubMed  Google Scholar 

  64. Prado JC Jr, Kupek E, Mion D Jr. Validity of four indirect methods to measure adherence in primary care hypertensives. J Hum Hypertens. 2007;21:579–84.

    PubMed  Google Scholar 

  65. Venter HL, Joubert PH, Foukaridis GN. Compliance in black patients with non-insulin-dependent diabetes mellitus receiving oral hypoglycaemic therapy. S Afr Med J. 1991;79:549–51.

    PubMed  CAS  Google Scholar 

  66. Babwah F, Baksh S, Blake L, et al. The role of gender in compliance and attendance at an outpatient clinic for type 2 diabetes mellitus in Trinidad. Rev Panam Salud Publica. 2006;19:79–84.

    Article  PubMed  Google Scholar 

  67. Cui J. Association of educational level and behavior of medical compliance with the level of blood glucose in diabetic patients. Chin J Clin Rehabil. 2005;2005:36.

    Google Scholar 

  68. Duff EM, O'Connor A, McFarlane-Anderson N, Wint YB, Bailey EY, Wright-Pascoe RA. Self-care, compliance and glycaemic control in JAMAican adults with diabetes mellitus. West Indian Med J. 2006;55:232–6.

    Article  PubMed  CAS  Google Scholar 

  69. Duran-Varela BR, Rivera-Chavira B, Franco-Gallegos E. Pharmacological therapy compliance in diabetes. Salud Publica Mex. 2001;43:233–6.

    Article  PubMed  CAS  Google Scholar 

  70. El-Shazly M, Abdel-Fattah M, Zaki A, et al. Health care for diabetic patients in developing countries: a case from Egypt. Public Health. 2000;114:276–81.

    Article  PubMed  CAS  Google Scholar 

  71. Garay-Sevilla ME, Nava LE, Malacara JM, et al. Adherence to treatment and social support in patients with non-insulin dependent diabetes mellitus. J Diabetes Complications. 1995;9:81–6.

    Article  PubMed  CAS  Google Scholar 

  72. Hanko B, Kazmer M, Kumli P, et al. Self-reported medication and lifestyle adherence in Hungarian patients with Type 2 diabetes. Pharm World Sci. 2007;29:58–66.

    Article  PubMed  Google Scholar 

  73. Hernandez-Ronquillo L, Tellez-Zenteno JF, Garduno-Espinosa J, Gonzalez-Acevez E. Factors associated with therapy noncompliance in type-2 diabetes patients. Salud Publica Mex. 2003;45:191–7.

    Article  PubMed  Google Scholar 

  74. Kaur K, Singh MM, Kumar, Walia I. Knowledge and self-care practices of diabetics in a resettlement colony of Chandigarh. Indian J Med Sci. 1998;52:341–7.

    PubMed  CAS  Google Scholar 

  75. Khattab MS, Aboifotouh MA, Khan MY, Humaidi MA, al-Kaldi YM. Compliance and control of diabetes in a family practice setting, Saudi Arabia. East Mediterr Health J. 1999;5:755–65.

    PubMed  CAS  Google Scholar 

  76. Roaeid RB, Kablan AA. Profile of diabetes health care at Benghazi Diabetes Centre, Libyan Arab JAMAhiriya. East Mediterr Health J. 2007;13:168–76.

    PubMed  CAS  Google Scholar 

  77. Srinivas G, Suresh E, Jagadeesan M, Amalraj E, Datta M. Treatment-seeking behavior and compliance of diabetic patients in a rural area of south India. Ann N Y Acad Sci. 2002;958:420–4.

    Article  PubMed  CAS  Google Scholar 

  78. Yousuf M, Ali M, Bano I. Non-compliance of drug therapy in diabetics- Experience at Lahore. Pakistan Journal of Medical Sciences. 2001;17:74–8.

    Google Scholar 

  79. Zhang CY, Xie S, Li Y, Li Z. Survey of the drug compliance of type 2 diabetic patients in Chenghai district of Shantou city. Chin J Clin Rehabil. 2005;9:14–5.

    CAS  Google Scholar 

  80. Bhagat K, Mazayi-Mupanemunda M. Compliance with medication in patients with heart failure in Zimbabwe. East Afr Med J. 2001;78:45–8.

    PubMed  CAS  Google Scholar 

  81. Joshi PP, Mohanan CJ, Sengupta SP, Salkar RG. Factors precipitating congestive heart failure–role of patient non-compliance. J Assoc Physicians India. 1999;47:294–5.

    PubMed  CAS  Google Scholar 

  82. Sadik A, Yousif M, McElnay JC. Pharmaceutical care of patients with heart failure. Br J Clin Pharmacol. 2005;60:183–93.

    Article  PubMed  CAS  Google Scholar 

  83. Moodley I. Analysis of a medical aid administrator database for costs and utilisation of benefits by patients claiming for lipid-lowering agents. Cardiovasc J S Afr. 2006;17:140–5.

    PubMed  Google Scholar 

  84. Asefzadeh S, Asefzadeh M, Javadi H. Care management: Adherence to therapies among patients at Bu-Alicina Clinic, Qazvin, Iran. Journal of Research in Medical Sciences. 2005;10:343–8.

    Google Scholar 

  85. Chizzola PR, Mansur AJ, da Luz PL, Bellotti G. Compliance with pharmacological treatment in outpatients from a Brazilian cardiology referral center. Sao Paulo Med J. 1996;114:1259–64.

    Article  PubMed  CAS  Google Scholar 

  86. Dantas RA, Aguillar OM, dos Santos Barbeira CB. Implementation of a nurse-monitored protocol in a Brazilian hospital: a pilot study with cardiac surgery patients. Patient Educ Couns. 2002;46:261–6.

    Article  PubMed  Google Scholar 

  87. El-Gatit AM, Haw M. Relationship between depression and non-adherence to anticoagulant therapy after valve replacement. East Mediterr Health J. 2003;9:12–9.

    PubMed  CAS  Google Scholar 

  88. Kocer A, Ince N, Kocer E, Tasci A. Factors influencing treatment compliance among Turkish people at risk for stroke. J Prim Prev. 2006;27:81–9.

    Article  PubMed  Google Scholar 

  89. Olubodun JO, Falase AO, Cole TO. Drug compliance in hypertensive Nigerians with and without heart failure. Int J Cardiol. 1990;27:229–34.

    Article  PubMed  CAS  Google Scholar 

  90. Rotchford AP, Rotchford KM. Diabetes in rural South Africa–an assessment of care and complications. S Afr Med J. 2002;92:536–41.

    PubMed  CAS  Google Scholar 

  91. Wiseman IC, Miller R. Quantifying non-compliance in patients receiving digoxin–a pharmacokinetic approach. S Afr Med J. 1991;79:155–7.

    PubMed  CAS  Google Scholar 

  92. Di Matteo M. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200–9.

    Article  Google Scholar 

  93. Chan DC, Shrank WH, Cutler D, et al. Patient, physician, and payment predictors of statin adherence. Med Care. 2010;48:196–202.

    Article  PubMed  Google Scholar 

  94. Gaziano, T. Cardiovascular disease in the developing world and its cost-effective management. Circulation. 2005;112:3547–53.

    Article  PubMed  Google Scholar 

  95. Woolf SH, Johnson RE. The break-even point: when medical advances are less important than improving the fidelity with which they are delivered. Ann Fam Med. 2005;3:545–52.

    Article  PubMed  Google Scholar 

  96. Green CA. What can patient health education coordinators learn from ten years of compliance research? Patient Education & Counseling. 1987;10:167–74.

    Article  CAS  Google Scholar 

  97. Kesselheim AS, Choudhry NK. The international pharmaceutical market as a source of low-cost prescription drugs for U.S. patients. Ann Intern Med. 2008;148:614–9.

    PubMed  Google Scholar 

  98. Mills EJ, Nachega JB, Bangsberg D, et al. Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-reported Barriers and Facilitators. PLoS Med. 2006;3:e438.

    Article  PubMed  Google Scholar 

  99. Choudhry NK, Fischer MA, Avorn J, et al. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med. 2011;171:814–22.

    Article  PubMed  Google Scholar 

  100. Choudhry NK. Promoting persistence: improving adherence through choice of drug class. Circulation. 2011;123:1584–6.

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

This work was not funded by any external sources.

Conflict of Interest

None disclosed.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Niteesh K. Choudhry MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bowry, A.D.K., Shrank, W.H., Lee, J.L. et al. A Systematic Review of Adherence to Cardiovascular Medications in Resource-Limited Settings. J GEN INTERN MED 26, 1479–1491 (2011). https://doi.org/10.1007/s11606-011-1825-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-011-1825-3

KEY WORDS

Navigation